Huxley SANSA Home Sleep Apnea Test (1000-00) vs Imbio PHA (4.0.0)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Huxley SANSA Home Sleep Apnea Test (1000-00)

by Huxley Medical

Imbio PHA (4.0.0)

by Imbio (a subsidiary of 4DMedical)

AI Verdict

Tool A is designed for remote diagnosis of sleep apnea and cardiac arrhythmias using a wearable patch and physiological data. Tool B, however, focuses on analyzing CT pulmonary angiogram scans to assess cardiac structures for pulmonary embolism and hypertension. While both leverage AI in cardiology, their distinct data sources and diagnostic targets make them suitable for different clinical workflows.

Choose Huxley SANSA Home Sleep Apnea Test (1000-00) if…

Choose Huxley SANSA if you require a convenient, app-free, and multi-day home monitoring solution for diagnosing sleep apnea and potential cardiac arrhythmias. This wearable patch is ideal for streamlining patient care by offering cellular-enabled data upload, reducing the burden on both patients and clinicians for remote diagnostics.

View Huxley SANSA Home Sleep Apnea Test (1000-00) →

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA if your clinical workflow involves analyzing CT pulmonary angiogram (CTPA) scans and you need rapid, automated measurements of cardiac structures. This AI-powered software is best suited for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by providing objective data on right ventricular dilation and other key ratios.

View Imbio PHA (4.0.0) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Huxley SANSA Home Sleep Apnea Test (1000-00)	Imbio PHA (4.0.0)
Deployment	Cloud-native platform, accessible from any browser.	Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA (Tool A) offers an 'app-free workflow' and 'cellular-enabled solution' with a 'comfortable and non-invasive' wearable patch, prioritizing ease of use for the patient in a home setting. Imbio PHA (Tool B) focuses on integration into existing clinical imaging workflows for professionals, which is valuable but less directly related to patient-facing usability for a diagnostic test.

Clinical Value

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA (Tool A) is an FDA-cleared device for the diagnosis of both home sleep apnea and cardiac arrhythmia, utilizing 9 physiological data channels and validated against polysomnography (PSG). Imbio PHA (Tool B) aids in the diagnosis and risk stratification of pulmonary embolism and hypertension by measuring cardiac structures from CTPA scans. While both offer significant clinical value, Tool A's ability to directly diagnose two distinct and prevalent conditions from a single, non-invasive home test provides a broad and impactful clinical utility.

Pricing & Value

Tie

Both Huxley SANSA (Tool A) and Imbio PHA (Tool B) state 'contact for pricing,' indicating a lack of public pricing transparency. Without specific pricing information or details on cost-effectiveness studies, it is impossible to determine which tool offers superior value.

Enterprise Readiness

Imbio PHA (4.0.0)

Imbio PHA (Tool B) offers flexible deployment options including 'Cloud, Enterprise (on-premise), or via partners' and explicitly 'integrates with native DICOM tools and workflows.' This demonstrates a higher degree of adaptability and readiness for integration into diverse hospital IT infrastructures compared to Huxley SANSA's (Tool A) cloud-based algorithm with cellular data upload.

Innovation

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA (Tool A) presents a highly innovative approach with its 'app-free workflow' and 'Built-in cellular data upload' for a multi-day, multi-channel wearable diagnostic patch. This significantly simplifies the patient experience for home diagnostics. While Imbio PHA (Tool B) utilizes AI for automated image analysis, Tool A's novel combination of patient-centric design and data acquisition methodology represents a more disruptive innovation in the diagnostic pathway.

Support & Docs

Tie

Neither the provided structured facts nor readily available web searches offer specific details regarding the level of support, documentation, or service level agreements for Huxley SANSA (Tool A) or Imbio PHA (Tool B). Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Huxley SANSA Home Sleep Apnea Test (1000-00)	Imbio PHA (4.0.0)
Name	Huxley SANSA Home Sleep Apnea Test (1000-00)	Imbio PHA (4.0.0)
Company	Huxley Medical	Imbio
Core Function	FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis.	FDA-cleared AI-powered medical image processing software for measuring cardiac structures from CTPA scans to assess right ventricular dilation and aid in diagnosis/risk stratification of pulmonary embolism and hypertension.
Primary Data Input/Modality	Wearable chest patch (9 physiological data channels)	CT pulmonary angiogram (CTPA) scans
Key Measurements/Outputs	ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, Sleep/Wake Staging; Multi-day monitoring capability.	Automated measurement of right and left ventricle diameters, main pulmonary artery and aorta diameters; calculates RV/LV and PA/Ao ratios; generates annotated DICOM images and PDF summary reports.
Specialties	Cardiology, Pulmonology, Sleep Medicine	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Huxley SANSA Home Sleep Apnea Test (1000-00) and Imbio PHA (4.0.0).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications for Huxley SANSA and Imbio PHA?

Huxley SANSA is an FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis. Imbio PHA is an FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.

What kind of patient data do these tools analyze?

Huxley SANSA collects and analyzes 9 physiological data channels, including ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, and Sleep/Wake Staging, via a wearable chest patch. Imbio PHA processes medical imaging data, specifically CT pulmonary angiogram (CTPA) scans, to measure cardiac structures.

What specific diagnostic measurements or insights do these tools provide?

Huxley SANSA provides AI-powered auto-scoring algorithms based on its 9 physiological data channels for sleep apnea and cardiac arrhythmia diagnosis, including ECG for arrhythmia detection. Imbio PHA automatically measures right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios from CTPA scans, generating annotated DICOM images and PDF summary reports.

Which medical specialties are these tools primarily designed to serve?

Both Huxley SANSA and Imbio PHA are relevant for Cardiology and Pulmonology. Additionally, Huxley SANSA is designed for Sleep Medicine, while Imbio PHA is also intended for Radiology.

Do these tools offer continuous monitoring or on-demand assessment?

Huxley SANSA offers multi-day monitoring capability through its wearable chest patch. Imbio PHA provides rapid, fully-automated assessment of CTPA scans, typically in minutes, for on-demand analysis.